Page 57 of 212
Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses
Leong WI, Ames RY, Haverkamp JM, Torres L, Kline J, Bans A, Rocha L, Gallotta M, Guiducci C, Coffman RL, Janatpour MJ. Oncotarget. 2019 Dec 31;10(68):7220-7237. PubMed
February 29, 2020
Regulation of gene expression by cis-acting long non-coding RNAs
Gil N, Ulitsky I. Nat Rev Genet. 2020 Feb;21(2):102-117. PubMed
The Dynamics of Cytoplasmic mRNA Metabolism.
Eisen TJ, Eichhorn SW, Subtelny AO, Lin KS, McGeary SE, Gupta S, Bartel DP. Mol Cell. 2019 Dec 30. pii: S1097-2765(19)30896-2. PubMed
January 31, 2020
Pharmacokinetics and Pharmacodynamics of the Small Interfering Ribonucleic Acid (siRNA), Givosiran, in Patients with Acute Hepatic Porphyria.
Agarwal S, Simon AR, Goel V, Habtemariam BA, Clausen VA, Kim JB, Robbie GJ. Clin Pharmacol Ther. 2020 Jan 29. PubMed
Page 57 of 212
Page 57 of 212
Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses
Leong WI, Ames RY, Haverkamp JM, Torres L, Kline J, Bans A, Rocha L, Gallotta M, Guiducci C, Coffman RL, Janatpour MJ. Oncotarget. 2019 Dec 31;10(68):7220-7237. PubMed
February 29, 2020
Regulation of gene expression by cis-acting long non-coding RNAs
Gil N, Ulitsky I. Nat Rev Genet. 2020 Feb;21(2):102-117. PubMed
The Dynamics of Cytoplasmic mRNA Metabolism.
Eisen TJ, Eichhorn SW, Subtelny AO, Lin KS, McGeary SE, Gupta S, Bartel DP. Mol Cell. 2019 Dec 30. pii: S1097-2765(19)30896-2. PubMed
January 31, 2020
Pharmacokinetics and Pharmacodynamics of the Small Interfering Ribonucleic Acid (siRNA), Givosiran, in Patients with Acute Hepatic Porphyria.
Agarwal S, Simon AR, Goel V, Habtemariam BA, Clausen VA, Kim JB, Robbie GJ. Clin Pharmacol Ther. 2020 Jan 29. PubMed
Page 57 of 212
